Effects of Atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease
Date
2004Author
ULUTIN, TURGUT
Kaya, Ayşem
TEKIN, A
TEKIN, G
GUREL, CİĞDEM
YIGIT, Zerrin
GUZELSOY, Deniz
Metadata
Show full item recordAbstract
Hyperlipidemic patients with coronary heart disease were treated with atorvastatin, and its effects on hemostatic and inflammatory parameters were assessed. After 3 months of therapy, the plasma levels of plasminogen activator inhibitor, prothrombin fragment 1+2, highly sensitive C-reactive protein, von Willebrand factor, and fibrinogen were significantly reduced; no significant reductions were observed in lipoprotein(a) and tissue plasminogen activator antigen levels. (C) 2004 by Excerpta Medica, Inc.
Collections
- Makale [92796]